GHRP-6
GHRP-6. First-generation ghrelin mimetic that produces a strong appetite signal alongside GH release.
How it works. Binds GHS-R1a in the pituitary for GH release and in hypothalamic NPY/AgRP neurons to trigger appetite.
What the research supports. 3 graded claims. Strongest: Useful in cachexia and appetite-loss research (preclinical).
Hormonal impact. Effects on Growth hormone, Ghrelin signaling, Cortisol, Prolactin.
Side effects and interactions. 1 medication interaction listed. Serious: Insulin resistance with chronic high-dose use.
Stacking. Pairs well with CJC-1295. Avoid combining with Active malignancy.
Common forms. Available as Subcutaneous injection.
Community. Experiences from people who have tried GHRP-6. Anecdotes are not medical advice.
GHRP-6. First-generation ghrelin mimetic that produces a strong appetite signal alongside GH release.
What it is
GHRP-6 is a synthetic hexapeptide that activates the ghrelin receptor, releasing GH and producing a pronounced hunger response.
How it works
Binds GHS-R1a in the pituitary for GH release and in hypothalamic NPY/AgRP neurons to trigger appetite.
Pathways
- GHS-R1a
- NPY/AgRP appetite circuit
Effects
- ↑Appetite increases
- ↑GH / IGF-1 axis activity increases
- +Recovery in catabolic states supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Hormonal impact
Side effects & interactions
Common side effects
- Intense hunger
- Water retention
- Flushing
Serious
- Insulin resistance with chronic high-dose use
Medication interactions
Hunger plus altered glucose handling can complicate dosing.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- CJC-1295GHRH analog amplifies the GH pulse without further raising appetite.
Avoid combining
- Active malignancyIGF-1 elevation is generally avoided.
Common forms
- Subcutaneous injection
Discussion
Loading discussion…